Joseph A Odin, MD, PhD
Liver Transplantation
About Me
Dr. Odin is a Professor in the Department of Medicine and the Recanati/Miller Transplantation Institute with a clinical background in gastroenterology and liver disease. He is co-director of the Mount Sinai Autoimmune Liver Disease Programs. He has research interest in liver autoimmunity and drug induced liver injury. His current research studies are focused on primary biliary cirrhosis, primary sclerosing cholangitis, autoimmune hepatitis, and evaluation of drug hepatotoxicity. He cares for individuals with all liver diseases including those with liver transplants. His research is supported by the NIH and he has received past support and awards from the American Gastroenterological Association and the American Association for the Study of Liver Disease. He also receives support from pharmaceutical companies for participation in clinical treatment trials for liver diseases.
Dr. Odin is an inaugural Fellow of the American Association for the Study of Liver Diseases (FAASLD) — the highest honor among AASLD membership categories — which recognizes superior professional achievement in clinical or academic practice, and in basic or clinical research.
RMTI Website: www.MountSinaiRMTI.org
Related Resource:
Autoimmune Liver Disease Treatment Program
Language
Position
Hospital Affiliations
- The Mount Sinai Hospital
About Me
Dr. Odin is a Professor in the Department of Medicine and the Recanati/Miller Transplantation Institute with a clinical background in gastroenterology and liver disease. He is co-director of the Mount Sinai Autoimmune Liver Disease Programs. He has research interest in liver autoimmunity and drug induced liver injury. His current research studies are focused on primary biliary cirrhosis, primary sclerosing cholangitis, autoimmune hepatitis, and evaluation of drug hepatotoxicity. He cares for individuals with all liver diseases including those with liver transplants. His research is supported by the NIH and he has received past support and awards from the American Gastroenterological Association and the American Association for the Study of Liver Disease. He also receives support from pharmaceutical companies for participation in clinical treatment trials for liver diseases.
Dr. Odin is an inaugural Fellow of the American Association for the Study of Liver Diseases (FAASLD) — the highest honor among AASLD membership categories — which recognizes superior professional achievement in clinical or academic practice, and in basic or clinical research.
RMTI Website: www.MountSinaiRMTI.org
Related Resource:
Autoimmune Liver Disease Treatment Program
Language
Position
Hospital Affiliations
- The Mount Sinai Hospital